MedTrace Logo

Ginger Capsules for the Prophylactic Treatment of Migraine

NCT02570633 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2020-03-16

No results posted yet for this study

Summary

The main objective of the study is to evaluate ginger efficacy as an prophylactic treatment of migraine.

Conditions

Interventions

OTHER

Extract of ginger

Migraine patients (both genders) will receive capsules of 200 mg of ginger extract (5% gingerols) to be taken three times a day for 12 weeks.

OTHER

Cellulose

Migraine patients (both genders) will receive capsules of 200 mg of placebo (cellulose) to be taken three times a day for 12 weeks.

Sponsors & Collaborators

  • Federal University of Minas Gerais

    lead OTHER

Principal Investigators

  • Adaliene VM Ferreira, PhD · Federal University of Minas Gerais

  • Laís B Martins, Ma · Federal University of Minas Gerais

  • Antônio L Teixeira, PhD · Federal University of Minas Gerais

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-07-31
Completion
2016-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02570633 on ClinicalTrials.gov